Form 4: Guidewire Software CEO Michael Rosenbaum Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Guidewire Software's CEO, Michael Rosenbaum, sold 1,400 shares of common stock on May 12, 2025, at a price of $216.51 per share, according to a pre-arranged 10b5-1 trading plan.
Summary
- Michael George Rosenbaum, CEO of Guidewire Software, Inc., reported a transaction involving the sale of company stock.
- On May 12, 2025, Rosenbaum sold 1,400 shares of common stock at a price of $216.51 per share.
- The sale was executed automatically under a 10b5-1 trading plan adopted on October 15, 2024.
- Following the transaction, Rosenbaum directly owns 251,593 shares of Guidewire Software common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive stock sale under a pre-arranged trading plan, suggesting a neutral sentiment.
Industry Context
Sales by executives are a normal part of executive compensation and wealth management. The use of a 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on inside information.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but the existence of a 10b5-1 trading plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date the Reporting Person adopted the 10b5-1 Trading Plan |
| 05/12/2025 | Date of the stock sale transaction |
| 05/14/2025 | Date of the Form 4 filing |
Keywords
Guidewire Software, GWRE, Michael Rosenbaum, Stock Sale, Form 4, 10b5-1 Trading Plan, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.